Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Pentobarbital sodium
WDT - Wirtschaftsgenossenschaft deutscher Tierarzte eG,
QN51AA01
Pentobarbital sodium
300 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Cattle, Chickens, Dogs, Guinea pigs, Hamsters, Mink, Non Food Animals, Non food-producing horses, Other Birds, Pigs, Rabbi
pentobarbital
Neurological Preparations
Authorised
2008-10-24
Health Products Regulatory Authority 27 August 2019 CRN00934R Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Release 300 mg/ml, solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains ACTIVE SUBSTANCE: pentobarbital sodium 300 mg EXCIPIENTS: patent blue V For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection A clear, blue solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, ponies, cattle, swine, dogs, cats, minks, polecats, hares, rabbits, guinea pigs, hamsters, rats, mice, chicken, pigeons, birds, snakes, tortoises, lizards, frogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For euthanasia in animals. 4.3 CONTRAINDICATIONS Do not use in animals intended for human or animal consumption. Do not use for anaesthetic purposes. Do not use for intracoelmic injection in chelonia as the time to death may be unnecessarily prolonged compared with intravenous administration. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Carcasses of animals euthanised with this product should be disposed of in accordance with national legislation. Carcasses of animals euthanised with this product should not be fed to other animals due to the risk of secondary intoxication. The intraperitoneal route of administration may cause a prolonged onset of action with an increased risk of adverse effects noted in 4.6. Prior sedation is advisable. The intrapulmonary route of administration may cause a prolonged onset of action with an increased risk of adverse effects noted in 4.6 and should be reserved for cases where other routes of administration are not possible. Prior sedation is mandatory before this route of administration is employed. When euthanasia of poikilotherms is undertaken, the animal must be maintained at its preferred optimum temperature, otherwise efficacy may be unreliable. Species appropriate measures (e.g. pithing) should be taken to ensure that euthanasia is complete in Belgenin tamamını okuyun